Related Experiment Video
Updated: Jul 26, 2026

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP
Published on: February 14, 2022
[Long-term oxygen therapy (LTOT) in chronic obstructive lung disease (COL)]
1H:S Frederiksberg Hospital, Intern Medicinsk Klinik.flem-mad@dadlnet.dk
Domiciliary oxygen therapy improves survival for chronic obstructive pulmonary disease patients with severe hypoxemia. It does not benefit those with moderate hypoxia or nocturnal desaturation.
Area of Science:
- Pulmonary Medicine
- Respiratory Health
- Clinical Trials
Background:
- Chronic obstructive pulmonary disease (COPD) significantly impacts patient survival and quality of life.
- Hypoxemia is a common complication in COPD patients, necessitating therapeutic interventions.
- Domiciliary oxygen therapy is a widely considered treatment for managing hypoxemia in COPD.
Purpose of the Study:
- To evaluate the efficacy of domiciliary oxygen therapy in improving survival rates among COPD patients.
- To assess the impact of long-term oxygen administration on the quality of life for individuals with COPD.
- To determine if oxygen therapy benefits COPD patients with varying degrees of hypoxemia and desaturation patterns.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials (RCTs) identified through the Cochrane Airways Group COPD register.
- Inclusion criteria focused on RCTs comparing long-term domiciliary oxygen therapy with control treatments in COPD patients with hypoxia.
- Data extraction was independently performed by two reviewers to ensure accuracy and reliability.
Main Results:
- Four RCTs were included, but data aggregation was not possible due to heterogeneity in trial design and patient selection.
- Continuous oxygen therapy showed a significant improvement in mortality at 24 months (Peto OR 0.45).
- Oxygen therapy demonstrated a significant survival benefit over five years in one trial (Peto OR 0.42), but no significant effect was observed in patients with moderate hypoxemia or nocturnal desaturation.
Conclusions:
- Long-term oxygen therapy is beneficial for survival in selected COPD patients experiencing severe hypoxemia (PaO2 < 8.0 kPa).
- Oxygen therapy does not appear to improve survival in COPD patients with moderate hypoxia or isolated nocturnal arterial desaturation.
- Further research may be needed to clarify optimal oxygen therapy protocols for different COPD patient subgroups.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Oxygen Delivering System III: Tracheostomy and T-piece
Tracheostomy
A tracheostomy is a surgically created opening (stoma) in the anterior part of the trachea. It is used to establish a patient airway, bypass an upper airway obstruction, simplify the removal of secretions, permit long-term...

